NCT07334457 Study of Platelet Population Changes Under Circulatory Support With ECMO
| NCT ID | NCT07334457 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Cardiac Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-03-11 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2025-03-11 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Advances in flow cytometry techniques have led to a better understanding of platelet phenotypes and have revealed the existence of four major platelet populations with distinct functional properties (native, proaggregating, procoagulating, or apoptotic). These phenotypes have a significant impact on the hemostatic capacity of blood platelets, and a proportional change in these populations during ECMO treatment could, at least in part, contribute to the observed complications.
Eligibility Criteria
Inclusion Criteria: * Adult patient (≥18 years) treated in one of the intensive care units of the Anesthesia and Intensive Care Department at Strasbourg University Hospital. * Implanted with veno-arterial or veno-venous ECMO within the previous 24 hours. Exclusion Criteria: * Subject who has expressed their opposition to participating in the study. * Subject under legal protection. * Subject under guardianship or curatorship.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07334457 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07334457 currently recruiting?
Yes, NCT07334457 is actively recruiting participants. Contact the research team at charlesambroise.tacquard@chru-strasbourg.fr for enrollment information.
Where is the NCT07334457 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT07334457 clinical trial?
NCT07334457 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 75 participants.